UnknownNot Applicable

Unplanned ICU Readmission for Pediatric Liver Transplantation

1,575 participantsStarted 2023-12-01

Plain-language summary

To explore the risk factors of unplanned return to Intensive Care Unit (ICU) in pediatric liver transplant recipients, and to provide data support for the transfer of pediatric liver transplant recipients from ICU after surgery, so as to avoid unplanned ICU return and reduce the mortality of patients during hospitalization.

Who can participate

Age range1 Month – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * (1) Liver transplantation was performed from January, 2018 to December, 31, 2021.21; * (2) Age \< 18 years; * (3) The patient was admitted to ICU for the first time due to postoperative monitoring after liver transplantation; * (4) Survival on first transfer from ICU. Exclusion Criteria: * (1) Death during ICU stay after liver transplantation; * (2) non-first-time recipients of liver transplantation; * (3) Patients with complex conditions who were transferred to ICU for life support (such as mechanical ventilation, CRRT, etc.) before operation; * (4) Patients admitted to ICU by appointment for surgical reasons. * (5) Patients forcibly transferred from ICU.

What they're measuring

Unplanned return to the ICU

Timeframe: 01/01/2018-31/12/2021

Trial details

NCT IDNCT06162260

SponsorRenJi Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-29

View on ClinicalTrials.gov More Liver Transplantation trials